Managing Hyperglycaemia During Antenatal Corticosteroid Administration in a Pregnant Woman with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System: Case Report
Authors:
- 8 February 2025
- journal article
- case report
- Published by Springer Nature in SN Comprehensive Clinical Medicine
- Vol. 7 (1) , 1-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Technology advances in diabetes pregnancy: right technology, right person, right timeDiabetologia, 2024
- Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trialThe Lancet Diabetes & Endocrinology, 2024
- Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancyDiabetic Medicine, 2023
- MiniMed TM 780G Advanced Hybrid Closed-Loop System Study in Pregnant Women with Type 1 DiabetesDiabetes Technology & Therapeutics, 2023
- Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop SystemDiabetes Technology & Therapeutics, 2023
- Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targetsThe Lancet Diabetes & Endocrinology, 2023
- Expert Guidance on Off-Label Use of Hybrid Closed-Loop Therapy in Pregnancies Complicated by DiabetesDiabetes Technology & Therapeutics, 2023
- Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes – an updated guideline from the Joint British Diabetes Society for Inpatient CareDiabetic Medicine, 2021
- Neonatal hypoglycemia after antenatal late preterm steroids in individuals with diabetesJournal of Perinatology, 2021
- Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trialThe Lancet, 2017